What is HighRes Biosolutions?
HighRes Biosolutions specializes in providing automated lab solutions, lab orchestration software, and precision automation technologies. Their core mission is to enhance accuracy, efficiency, and scalability for life science organizations by implementing intelligent data and lab automation workflows. The company's offerings encompass modular automation platforms, precision liquid handling solutions, and the unified Cellario software platform, which seamlessly integrates hardware, workflows, and data. HighRes primarily serves sectors such as drug discovery, genomics, and synthetic biology, aiming to accelerate scientific research and contribute to improved human health outcomes.
How much funding has HighRes Biosolutions raised?
HighRes Biosolutions has raised a total of $2.5M across 1 funding round:
Private Equity
$2.5M
Private Equity (2015): $2.5M, investors not publicly disclosed
What's next for HighRes Biosolutions?
The substantial enterprise-level funding received by HighRes Biosolutions positions the company for accelerated growth and innovation in the highly competitive life science automation market. This strategic investment is expected to fuel further development of their advanced automation platforms and software solutions, potentially expanding their market reach and deepening their impact on scientific research. The company's focus on integrating hardware and software to create intelligent workflows suggests a continued emphasis on providing comprehensive, end-to-end solutions for complex laboratory challenges, thereby solidifying their position as a key player in enabling reproducible and efficient scientific processes.
See full HighRes Biosolutions company page
